Announced
Completed
Financials
Tags
digital health
Completed
biotechnology
predictive analytics
mhealth
United States
Private
Friendly
Single Bidder
Biotechnology
digital therapeutics
Acquisition
Private Equity
Minority
Venture Capital
Cross Border
Synopsis
SoftBank Vision Fund 2 led a $100m Series C funding round in Biofourmis, a digital therapeutics and personalized predictive care services provider. The round saw participation from existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. "We believe predictive health is the future of medicine and Biofourmis is a leader in using AI and machine learning-based solutions to advance digital therapeutics. We are excited to partner with Biofourmis and support their mission of using AI and wearables data to enable personalized care," Greg Moon, SoftBank Managing Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.